Liposomal bupivacaine is named as a drug or biological intervention in 15 clinical trials in our China and USA trial registers, 10 of which are recruiting. Lead sponsors include Beijing Tiantan Hospital (6), TLC Biopharmaceuticals, Inc. (1) and The Second Affiliated Hospital of Chongqing Medical University (1). Registered phases: Not applicable, Phase 4 and Phase 3. Conditions studied include Liposomal Bupivacaine; Postoperative Pain; Pain Management.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Liposomal Bupivacaine | 7 |
| Postoperative Pain | 4 |
| Pain Management | 3 |
| Laparoscopic Surgery | 3 |
| Video-assisted Thoracoscopic Surgery (VATS) | 2 |
| Acute Pain | 2 |
| Liposome Bupivacaine | 2 |
| Local Infiltration | 2 |
| Transversus Abdominis Plane Block | 2 |
| Local Injection | 1 |
| Chronic Pain | 1 |
| Total Knee Anthroplasty | 1 |
| Nerve Block | 1 |
| Ropivacaine | 1 |
| Orthopaedic Surgery | 1 |
| Postoperative Ileus | 1 |
| Pain Syndrome | 1 |
| Dizziness | 1 |
| Vomiting | 1 |
| Itching | 1 |
| Hemorrhoid Surgery | 1 |
| Proximal Humerus Surgery | 1 |
| Rotator Cuff Surgery | 1 |
| Shoulder Arthroplasty | 1 |
| Shoulder Arthroscopy | 1 |
| Erector Spinae Plane Block | 1 |
| Postoperative Analgesia | 1 |
| Randomized Controlled Trial | 1 |
| Rhomboid Intercostal Block | 1 |
| Gynecologic Oncology Patient | 1 |
| Fascia Iliaca Block | 1 |
| Hip Surgery | 1 |
| Lead sponsor | Trials |
|---|---|
| Beijing Tiantan Hospital | 6 |
| TLC Biopharmaceuticals, Inc. | 1 |
| The Second Affiliated Hospital of Chongqing Medical University | 1 |
| Huazhong University of Science and Technology | 1 |
| Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 1 |
| Tianjin First Central Hospital | 1 |
| Zhejiang Cancer Hospital | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Peking University First Hospital | 1 |
| Register | Liposomal bupivacaine trials |
|---|---|
| Clinical trials in China | 14 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Liposomal bupivacaine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Liposomal bupivacaine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.